Glenn J. Smits

861 total citations
25 papers, 725 citations indexed

About

Glenn J. Smits is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Organic Chemistry. According to data from OpenAlex, Glenn J. Smits has authored 25 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 10 papers in Physiology and 6 papers in Organic Chemistry. Recurrent topics in Glenn J. Smits's work include Adenosine and Purinergic Signaling (10 papers), Heart Failure Treatment and Management (6 papers) and Cardiac Ischemia and Reperfusion (6 papers). Glenn J. Smits is often cited by papers focused on Adenosine and Purinergic Signaling (10 papers), Heart Failure Treatment and Management (6 papers) and Cardiac Ischemia and Reperfusion (6 papers). Glenn J. Smits collaborates with scholars based in United States and Switzerland. Glenn J. Smits's co-authors include Richard J. Roman, Julian H. Lombard, Mark H. Perrone, Kenneth L. Clark, B. F. Cox, Xiaowei Jin, J P Koepke, Russell C. Petter, Edward H. Blaine and Gillian M. Olins and has published in prestigious journals such as Journal of Applied Physiology, Hypertension and Journal of Medicinal Chemistry.

In The Last Decade

Glenn J. Smits

25 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenn J. Smits United States 15 213 194 192 143 101 25 725
Helen Maddock United Kingdom 15 291 1.4× 121 0.6× 287 1.5× 252 1.8× 26 0.3× 53 790
Nicholas A. Flores United Kingdom 14 319 1.5× 108 0.6× 140 0.7× 104 0.7× 11 0.1× 34 619
Nicholas King United States 13 232 1.1× 65 0.3× 231 1.2× 43 0.3× 11 0.1× 31 1.3k
Mark W. Gorman United States 20 787 3.7× 202 1.0× 305 1.6× 207 1.4× 12 0.1× 37 1.5k
J. Craig Hartman United States 15 364 1.7× 41 0.2× 146 0.8× 323 2.3× 8 0.1× 30 899
Francis L. Belloni United States 16 392 1.8× 142 0.7× 148 0.8× 232 1.6× 5 0.0× 35 878
Stephen Ely United States 16 421 2.0× 156 0.8× 150 0.8× 376 2.6× 5 0.0× 29 925
H. Thomas Lee United States 12 43 0.2× 240 1.2× 231 1.2× 171 1.2× 15 0.1× 14 770
Andreas Redel Germany 17 198 0.9× 24 0.1× 142 0.7× 437 3.1× 19 0.2× 35 804
Hiroharu Funaya Japan 13 480 2.3× 135 0.7× 163 0.8× 324 2.3× 4 0.0× 19 938

Countries citing papers authored by Glenn J. Smits

Since Specialization
Citations

This map shows the geographic impact of Glenn J. Smits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn J. Smits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn J. Smits more than expected).

Fields of papers citing papers by Glenn J. Smits

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn J. Smits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn J. Smits. The network helps show where Glenn J. Smits may publish in the future.

Co-authorship network of co-authors of Glenn J. Smits

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn J. Smits. A scholar is included among the top collaborators of Glenn J. Smits based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn J. Smits. Glenn J. Smits is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tofovic, Stevan P., Eman Salah, Glenn J. Smits, et al.. (2016). Dual A1/A2B Receptor Blockade Improves Cardiac and Renal Outcomes in a Rat Model of Heart Failure with Preserved Ejection Fraction. Journal of Pharmacology and Experimental Therapeutics. 356(2). 333–340. 15 indexed citations
2.
Kiesman, William F., Jin Zhao, Patrick R. Conlon, et al.. (2006). Norbornyllactone-substituted xanthines as adenosine A1 receptor antagonists. Bioorganic & Medicinal Chemistry. 14(11). 3654–3661. 16 indexed citations
3.
Vu, Chi B., William F. Kiesman, Patrick R. Conlon, et al.. (2006). Tricyclic Imidazoline Derivatives as Potent and Selective Adenosine A1Receptor Antagonists. Journal of Medicinal Chemistry. 49(24). 7132–7139. 13 indexed citations
4.
Auchampach, John A., Xiaowei Jin, Jeannine Moore, et al.. (2004). Comparison of Three Different A1 Adenosine Receptor Antagonists on Infarct Size and Multiple Cycle Ischemic Preconditioning in Anesthetized Dogs. Journal of Pharmacology and Experimental Therapeutics. 308(3). 846–856. 36 indexed citations
5.
Vu, Chi B., Bo Peng, G. Kumaravel, et al.. (2004). Novel Diamino Derivatives of [1,2,4]Triazolo[1,5-a][1,3,5]triazine as Potent and Selective Adenosine A2aReceptor Antagonists. Journal of Medicinal Chemistry. 48(6). 2009–2018. 52 indexed citations
6.
Vu, Chi B., Bo Peng, G. Kumaravel, et al.. (2004). Piperazine Derivatives of [1,2,4]Triazolo[1,5-a][1,3,5]triazine as Potent and Selective Adenosine A2aReceptor Antagonists. Journal of Medicinal Chemistry. 47(17). 4291–4299. 35 indexed citations
7.
Hendrick, Jennifer W., Rupak Mukherjee, G. Patricia Escobar, et al.. (2002). Cardiorenal Effects of Adenosine Subtype 1 (A1) Receptor Inhibition in an Experimental Model of Heart Failure1. Journal of the American College of Surgeons. 194(5). 603–609. 18 indexed citations
8.
Jackson, Edwin K., Curtis K. Kost, William A. Herzer, Glenn J. Smits, & Stevan P. Tofovic. (2001). A(1) receptor blockade induces natriuresis with a favorable renal hemodynamic profile in SHHF/Mcc-fa(cp) rats chronically treated with salt and furosemide.. PubMed. 299(3). 978–87. 13 indexed citations
9.
Jackson, Edwin K., Curtis K. Kost, William A. Herzer, Glenn J. Smits, & Stevan P. Tofovic. (2001). A1 Receptor Blockade Induces Natriuresis with a Favorable Renal Hemodynamic Profile in SHHF/Mcc-facp Rats Chronically Treated with Salt and Furosemide. Journal of Pharmacology and Experimental Therapeutics. 299(3). 978–987. 8 indexed citations
10.
Hendrick, Jennifer W., Cassandra Joffs, Jennifer Nerissa Davis, et al.. (2001). Effects of Adenosine Receptor Subtype A 1 on Ventricular and Renal Function. Journal of Cardiovascular Pharmacology. 38(4). 618–624. 10 indexed citations
11.
McVey, Matthew J., Glenn J. Smits, Bryan F. Cox, et al.. (1999). Cardiovascular Pharmacology of the Adenosine A1/A2-Receptor Agonist AMP 579: Coronary Hemodynamic and Cardioprotective Effects in the Canine Myocardium. Journal of Cardiovascular Pharmacology. 33(5). 703–710. 32 indexed citations
12.
Smits, Glenn J., et al.. (1998). Cardioprotective Effects of the Novel Adenosine A1/A2 Receptor Agonist AMP 579 in a Porcine Model of Myocardial Infarction. Journal of Pharmacology and Experimental Therapeutics. 286(2). 611–618. 79 indexed citations
13.
Merkel, Linda, Camilo Rojas, Michael F. Jarvis, et al.. (1998). Pharmacological characterization of AMP 579, a novel adenosine A1/A2 receptor agonist and cardioprotective. Drug Development Research. 45(1). 30–43. 12 indexed citations
14.
Smits, Glenn J., Mark H. Perrone, & Bryan F. Cox. (1997). Regional Hemodynamic Dose-Response of Lemakalim and Glybenclamide in Anesthetized Rats. Journal of Cardiovascular Pharmacology. 29(1). 49–56. 8 indexed citations
15.
Merkel, Linda, Eric D. Hawkins, Dennis Colussi, et al.. (1995). Cardiovascular and Antilipolytic Effects of the Adenosine Agonist GR79236. Pharmacology. 51(4). 224–236. 27 indexed citations
16.
Reitz, David B., Gillian M. Olins, Ellen G. McMahon, et al.. (1993). Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonists. Journal of Medicinal Chemistry. 36(15). 2172–2181. 20 indexed citations
17.
Olins, Gillian M., Glenn J. Smits, J P Koepke, et al.. (1993). In Vivo Pharmacology of SC-51316, a Nonpeptidic Angiotensin II Receptor Antagonist. American Journal of Hypertension. 6(7 Pt 1). 619–625. 5 indexed citations
18.
Smits, Glenn J., Jan M. Kitzen, Mark H. Perrone, & B. F. Cox. (1993). Angiotensin subtype 1 blockade selectively potentiates adenosine subtype 2-mediated vasodilation.. Hypertension. 22(2). 221–230. 9 indexed citations
19.
Trapani, Angelo J., Glenn J. Smits, Kerry L. Spear, et al.. (1989). Thiorphan, an Inhibitor of Endopeptidase 24.11, Potentiates the Natriuretic Activity of Atrial Natriuretic Peptide. Journal of Cardiovascular Pharmacology. 14(3). 419–424. 42 indexed citations
20.
Sheldahl, Lois M., Felix E. Tristani, Philip S. Clifford, et al.. (1986). Effect of head-out water immersion on response to exercise training. Journal of Applied Physiology. 60(6). 1878–1881. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026